Content provided by Oracle Health Sciences | 01-Nov-2015
| White Paper
The new white paper, “Accelerating Data Cleaning, Integration & Analysis from Source to Submission,” examines how Oracle Health Sciences Data Management...
Content provided by Oracle Health Sciences | 22-Oct-2015
| Case Study
PPD, one of the top CROS worldwide, is reducing trial timelines, cost, and risk through simplified data exchange and monitoring with Oracle Siebel CTMS...
Content provided by World Courier | 12-Oct-2015
| Case Study
Two of the biggest challenges in today’s global clinical trials are patient recruitment and retention. These problems often spring from clinical trial...
Content provided by Catalent | 31-Aug-2015
| White Paper
Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals. These studies are a key component...
Content provided by RSSL | 02-Jul-2015
| White Paper
Billions of patients worldwide benefit from a diverse range of medical devices. The global medical device market in 2011 was approximately $300 billion...
Content provided by World Courier | 16-Jun-2015
| Infographic
Download World Courier’s latest piece which shares the story of the changes in temperature-controlled transport and what these trends mean to your business....
Content provided by AdvantaPure® | 08-Jun-2015
| White Paper
Pharmaceutical fluid transfer involves many tubing-to-fitting connections, and unfortunately those connections can leak and result in contamination, production...
Content provided by SGS Life Science Services | 20-Apr-2015
| White Paper
Within the pharmaceutical industry, there are six dominant methods used to model outsourcing strategy. This white paper details how a hybrid strategy can...
Merck KGaA, Darmstadt, Germany | Recorded the 09-Apr-2015 | Webinar
Pyrogens in pharmaceuticals, medical devices, biotherapeutics and cosmetics can cause fevers in humans and are potentially life-threatening. Yet standard...
Content provided by Catalent | 26-Jan-2015
| White Paper
Assessment of biosimilar molecules requires an orthogonal analytical approach. Any one particular analytical technique is not able to fully define the...
